Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulants
Author:
- 17 April 2013
- journal article
- review article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 35 (3) , 269-274
Abstract
Summary: Antiphospholipid antibodies (aPL) comprise a heterogeneous group of antibodies directed against phospholipids and/or protein‐complexed phospholipids. aPL are associated with the serious autoimmune condition ‘antiphosholipid (antibody) syndrome’ (APS) and can be defined by either ‘solid‐phase’ assays that identify anticardiolipin antibodies (aCL) and anti‐β2‐glycoprotein I antibodies (aB2GPI) or ‘liquid‐phase’ assays that identify lupus anticoagulants (LAs). There is a lack of standardization associated with all forms of aPL testing; however, intermethod and interlaboratory variation using aCL and aB2GPI assays is generally higher than that for LA testing by dRVVT (dilute russell viper venom time) procedures. Compared with either aCL or aB2GPI, LA is also more strongly associated with clinically adverse findings of APS, including thrombosis and obstetric morbidity. This review explores the potential reasons for the above findings and concludes that ultimately a more holistic approach to aPL/APS investigations is needed.Keywords
This publication has 23 references indexed in Scilit:
- Trials and tribulations in lupus anticoagulant testingClinical Chemistry and Laboratory Medicine (CCLM), 2012
- Internal Quality Control and External Quality Assurance in Testing for Antiphospholipid Antibodies: Part I—Anticardiolipin and Anti-β2-Glycoprotein I AntibodiesSeminars in Thrombosis and Hemostasis, 2012
- Pathogenesis of the Antiphospholipid SyndromeSeminars in Thrombosis and Hemostasis, 2012
- Standards and reference materials for the anticardiolipin and anti-β2glycoprotein I assays: A report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid AntibodiesClinica Chimica Acta, 2012
- Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assaysClinical Chemistry and Laboratory Medicine (CCLM), 2011
- The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours?Autoimmunity Highlights, 2010
- Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practiceLupus, 2010
- Update of the guidelines for lupus anticoagulant detectionJournal of Thrombosis and Haemostasis, 2009
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literatureBlood, 2003